药品价格管制关系着人民群众看病就医和医药卫生事业的健康发展,是国内各方关注的焦点。药品价格管制在控制医药费用过快增长、促进社会整体健康效益改善、协调相关各方利益关系等方面发挥着重要作用,但本身也面临诸多质疑、问题和挑战。药品价格虚高、价格管理体系混乱、医药费用过快上涨等问题始终困扰医药卫生体制改革、影响群众看病就医、阻碍医药卫生事业健康可持续发展,也使药品价格管制的作用和效果受到广泛质疑,更为不幸的是,管制本身甚至被认为是造成问题的重要原因。因此,为了更好地配合中国医药卫生体制改革,必须对药品价格管制进行系统总结,吸取经验教训,深化管制创新,寻求更多联动配套政策工具,消减价格政策扭曲效果,努力使医药费用控制与人民健康效益改善两个不同目标能得以兼顾。
<<Pharmaceuticals price regulation is related to the masses seeing a doctor and the healthy development of the pharmaceutical and healthcare fields,and it is the focus in China.Pharmaceuticals price regulation plays an important role in controlling the excessively rapid growth of medical costs,promoting overall health benefits of the society,coordinating the interests of all related parties and so on,but is also facing many questions,problems and challenges. The problems such as drug prices are artificially high,price management system chaos and medical costs rise too fast always trouble the medical and health care system reform,affect the masses seeing a doctor,and impede the healthy sustainable development of the pharmaceutical and healthcare fields,and these problems also cause the widespread suspicion about the role and effect of pharmaceuticals price regulation,and more unfortunately,the price regulation itself is considered as an important reason for the problems. Therefore,in order to better cooperate with Chinese medical and health care system reform,we must carry on the system summary of pharmaceuticals price regulation,draw lessons from experience,deepen the regulation innovation,seek more linked and matching policy tools,cut price policy distortion effect,and balance medical costs control and improvement of people’s health benefits.
<<